Sheba Medical Center, Tel Hashomer, Israel
1 June, 2011
A clinical trial in obsessive compulsive disorder (OCD) patients has begun at the Sheba Medical Center, Tel Hashomer, Israel.
The purpose of this study is to test whether the combination of Brainsway® Deep transcranial magnetic stimulation (Deep TMS) treatment with customary medication for OCD patients confers additional benefits over treatment that includes only medication.
30 OCD patients are expected to participate in the trial.